1.
Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial
by Holman, Rury R., FRCP, FMedSci
The American heart journal, 2016, Vol.174, p.103-110
2.
Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial
by Farkouh, Michael E., MD, MSc
The American heart journal, 2008, Vol.155 (2), p.215-223
3.
Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label...
by Buse, John B., MD, PhD
Clinical therapeutics, 2007, Vol.29 (1), p.139-153
4.
Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Tr...
by Goff, David C., MD, PhD
The American journal of cardiology, 2007, Vol.99 (12), p.S4-S20
5.
Evaluation of the dual peroxisome proliferator–activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabet...
by Lincoff, A. Michael, MD
The American heart journal, 2013, Vol.166 (3), p.429-434.e1
6.
7.
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
by Buse, John B, Prof
The Lancet (British edition), 2013, Vol.381 (9861), p.117-124
8.
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
by Drucker, Daniel J, Dr
The Lancet (British edition), 2008, Vol.372 (9645), p.1240-1250
9.
Defeating AIDS—advancing global health
by Piot, Peter, Prof
The Lancet (British edition), 2015, Vol.386 (9989), p.171-218
10.
Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial
by Marso, Steven P., MD
The American heart journal, 2013, Vol.166 (5), p.823-830.e5
11.
Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial
by El-Khatib, Firas H, PhD
The Lancet (British edition), 2016, Vol.389 (10067), p.369-380
